FDA Drugs recall ·
Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets… recall
- Recall number
- D-0239-2026
- Date
- (initiated November 17, 2025)
- Company / brand
- Preferred Pharmaceuticals, Inc.
1250 N Lakeview Ave Ste O, Anaheim, CA, United States - Category
- Drugs › Class II
- Classification
- Class II
- Status
- Ongoing
- Units affected
- 575 1x10 Foil Blister Packs
- Hazard tags
- Fall
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred Pharmaceuticals NDC 68788-8666-01
Why was it recalled?
Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lot: J1325J, I1725P, EXP Date: 4/30/2027.
Distribution
Natinowide in the USA
What does Class II mean?
Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.
Source: FDA (drugs), recall D-0239-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.